ArticleSmall science2026
Dissecting the Structural Features of Folding Asymmetry and Transient Misfolding in a Multidomain PDZ Scaffold.
Article in Small science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Determinants of Protein Folding Pathways: Lessons from Metamorphic Proteins.International journal of molecular sciences · 2026Review
- Dissecting the Structural Features of Folding Asymmetry and Transient Misfolding in a Multidomain PDZ Scaffold.Small science · 2026Article
- Adjacent domains drive the emergence of misfolded intermediates in the folding pathway of the PDZ4 from MAGI1.BBA advances · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Understanding how multidomain proteins fold, avoid misfolding, and maintain functional regulation represents a critical problem in structural biology, with broad relevance for biotechnology. In this study, the tandem PDZ1-PDZ2 domains of the scaffold protein X11, a system of particular interest due to its previously reported asymmetric folding and unfolding behavior as well as its propensity to form transient misfolded intermediates, are investigated. Through extensive mutational work and in-depth kinetic folding analysis, the folding behavior of this multidomain construct is dissected, and a comparative analysis with its isolated PDZ domains is also performed. The results reveal that folding and unfolding proceed through distinct pathways with PDZ2 folding rapidly and independently, while PDZ1 folds more slowly and only upon engagement of an autoinhibitory regulatory tail. Despite these differences, the folding mechanisms of each domain are conserved when studied in isolation, with deviations largely confined to functionally relevant and frustrated regions. The results also allow to depict the structural features of a misfolded intermediate that competes with productive folding and is stabilized by non-native interdomain contacts. Strikingly, this misfolded trap retains elements of the PDZ2 folding nucleus, an unexpected finding that allows us to draw broader conclusions about how transient misfolding can arise even from native-like structural motifs. We discuss these results in light of prior studies on multidomain proteins.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.